Remarkably, PD-L2 expression was significantly decreased on B cells in patients with CLL (0.3967 ± 0.3343) compared to the control group (2.870 ± 2.800; p = 0.0003) (Figure 3C). This evidence concerns the gene PDCD1LG2 and B-cell chronic lymphocytic leukemia.